The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: A gynecologic oncology group study Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • CA-125 Antigen
  • Carcinoma
  • Ovarian Neoplasms

abstract

  • A normal CA 125 level in the setting of advanced EOC was rare even after surgical debulking. The pretreatment CA 125 level was an independent predictor of PFS in patients with advanced EOC who received a standard chemotherapy regimen, particularly in the setting of disease that was debulked to a microscopic residual and in the serous or endometrioid subtypes.

publication date

  • March 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2664510

Digital Object Identifier (DOI)

  • 10.1002/cncr.24084

PubMed ID

  • 19156927

Additional Document Info

start page

  • 1028

end page

  • 35

volume

  • 115

number

  • 5